| 05.05. | Announcement from Xbrane Biopharma's annual general meeting |  |
| 05.05. | TRANSCRIPT : Xbrane Biopharma AB, Q1 2022 Earnings Call, May 05, 2022 | |
| 05.05. | Xbrane Biopharma releases interim report for January – March 2022 | |
| 05.05. | Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 02.05. | Invitation to presentation of Xbrane Biopharma's interim report January – March 2.. | |
| 05.04. | Correction regarding notice of annual general meeting in Xbrane Biopharma | |
| 04.04. | Notice of annual general meeting in Xbrane Biopharma AB | |
| 31.03. | Xbrane Biopharma releases annual report 2021 | |
| 09.03. | Xbrane Biopharma - Xciting and Increasingly Compelling Case | |
| 24.02. | TRANSCRIPT : Xbrane Biopharma AB, Q4 2021 Earnings Call, Feb 24, 2022 | |
| 24.02. | Xbrane Biopharma releases Year-end report 2021 | |
| 24.02. | Xbrane Biopharma AB Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 23.02. | Invitation to presentation of xbrane biopharma's year-end report 2021 on february 24, 2.. | |
| 22.02. | Invitation to presentation of Xbrane Biopharma's Year-end report 2021 on February 24, 2.. | |
| 17.02. | Biogen And Xbrane Enter Into Worldwide Commercialization And License Agreement For Cert.. | |
| 17.02. | Xbrane provides an update on its subsidiary Primm Pharma | |
| 16.02. | Xbrane announces positive top-line results from the pivotal phase iii equivalence trial.. | |
| 15.02. | Xbrane announces positive top-line results from the pivotal phase III equivalence trial.. | |
| 15.02. | Xbrane Biopharma AB Announces Positive Top-Line Results from the Pivotal Phase III Equi.. | |
| 08.02. | Biogen and xbrane announce commercialization and license agreement for proposed biosimi.. | |
| 08.02. | TRANSCRIPT : Xbrane Biopharma AB - Special Call | |
| 07.02. | Xbrane invites to a webcast related to the announcement of the commercialization and li.. | |
| 07.02. | Biogen and Xbrane Announce Commercialization and License Agreement for Proposed Biosimi.. | |
| 07.02. | Biogen Inc. and Xbrane Biopharma AB Announce Commercialization and License Agreement fo.. | |
| 18.01. | Xbrane Biopharma changes the date for Interim and Year-end Report | |
| 04.01. | XBRANE BIOPHARMA AB(OM : XBRANE) dropped from OMX Nordic Small Cap Index | |
| 2021 | Certain Shares of Xbrane Biopharma AB are subject to a Lock-Up Agreement Ending on 28-D.. | |
| 2021 | Xbrane Biopharma moves to Nasdaq Stockholm Mid Cap segment | |
| 2021 | Xbrane has initiated development of two new biosimilar candidates, building an oncology.. | |
| 2021 | TRANSCRIPT : Xbrane Biopharma AB - Special Call | |
| 2021 | Xbrane has initiated development of two new biosimilar candidates, building an oncology.. | |
| 2021 | Xbrane Biopharma releases interim report for January - September 2021 | |
| 2021 | Invitation to presentation of xbrane biopharma's interim report january - september, 20.. | |
| 2021 | TRANSCRIPT : Xbrane Biopharma AB, Nine Months 2021 Earnings Call, Oct 29, 2021 | |
| 2021 | Interim Report January – September 2021 | |
| 2021 | Xbrane Biopharma releases interim report for January – September 2021 | |
| 2021 | Xbrane Biopharma AB Reports Earnings Results for the Third Quarter and Nine Months Ende.. | |
| 2021 | Invitation to presentation of Xbrane Biopharma's interim report January – Septemb.. | |
| 2021 | Xbrane announces four more patents granted | |
| 2021 | XBRANE BIOPHARMA : presents Nomination Committee | |
| 2021 | Xbrane Biopharma Presents Nomination Committee | |
| 2021 | XBRANE BIOPHARMA : announces two granted patents that strengthens its high yield protein e.. | |
| 2021 | Xbrane Biopharma AB announces two granted patents that strengthens its high yield prote.. | |
| 2021 | XBRANE BIOPHARMA : enters agreement with AGC Biologics | |
| 2021 | XBRANE BIOPHARMA : and AGC Biologics enter into an Agreement to Manufacture Xcimzane&trade.. | |
| 2021 | Xbrane Biopharma AB and AGC Biologics Enter into an Agreement to Manufacture Xcimzane™ .. | |
| 2021 | XBRANE BIOPHARMA AB : announces that partner STADA's Marketing Authorization Application f.. | |
| 2021 | Certain Shares of Xbrane Biopharma AB are subject to a Lock-Up Agreement Ending on 29-S.. | |
| 2021 | XBRANE BIOPHARMA AB(OM : XBRANE) added to S&P Global BMI Index | |
| 2021 | XBRANE BIOPHARMA : Releases interim report for january - june 2021 | |
| 2021 | TRANSCRIPT : Xbrane Biopharma AB, H1 2021 Earnings Call, Aug 13, 2021 | |
| 2021 | XBRANE BIOPHARMA : Interim Report January – June 2021 | |
| 2021 | XBRANE BIOPHARMA : releases interim report for January – June 2021 | |
| 2021 | Xbrane Biopharma AB Publ Reports Earnings Results for the Second Quarter Ended June 30,.. | |
| 2021 | XBRANE BIOPHARMA : Invitation to presentation of Xbrane Biopharma's interim report January.. | |
| 2021 | XBRANE BIOPHARMA : A bright future | |
| 2021 | XBRANE BIOPHARMA : Change of number of shares and votes in Xbrane | |
| 2021 | XBRANE BIOPHARMA : certified as a Great Place to Work® | |
| 2021 | XBRANE BIOPHARMA : has carried out a directed share issue raising gross proceeds of SEK 38.. | |
| 2021 | XBRANE BIOPHARMA : announces intention to carry out a directed share issue | |
| 2021 | XBRANE BIOPHARMA : Change of number of shares and votes in xbrane | |
| 2021 | XBRANE BIOPHARMA : XlucaneTM meets the primary endpoint in the pivotal Phase III trial wit.. | |
| 2021 | XBRANE BIOPHARMA : Xlucane™ meets the primary endpoint in the pivotal Phase III tria.. | |
| 2021 | Xbrane Biopharma AB Announces Top-Line Results from the 6 Months Interim Read-Out in th.. | |
| 2021 | XBRANE BIOPHARMA : announces ambition to generate positive operating cash flow monthly by .. | |
| 2021 | XBRANE BIOPHARMA : is hosting a Virtual Capital Markets Day on May 17th, 2021 | |
| 2021 | Certain Shares of Xbrane Biopharma AB are subject to a Lock-Up Agreement Ending on 10-M.. | |
| 2021 | XBRANE BIOPHARMA : Announcement from Xbrane Biopharma's annual general meeting | |
| 2021 | XBRANE BIOPHARMA : Announcement from Xbrane Biopharma's annual general meeting | |
| 2021 | XBRANE BIOPHARMA : releases interim report for January – March 2021 | |
| 2021 | Xbrane Biopharma AB Publ Reports Earnings Results for the First Quarter Ended March 31,.. | |
| 2021 | XBRANE BIOPHARMA : Invitation to presentation of Xbrane Biopharma's interim report January.. | |
| 2021 | XBRANE BIOPHARMA : expands in-house Biosimilar development capabilities with new Biotech l.. | |
| 2021 | XBRANE BIOPHARMA : releases Annual report for 2020 | |
| 2021 | Xbrane Biopharma AB Auditor Raises 'Going Concern' Doubt | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
